MAR 16, 2021 8:00 AM PDT

The latest developments for enriching and analyzing antigen- and virus-specific T cells

Sponsored by: Miltenyi Biotec
Speaker

Event Date & Time

DATE:  March 16, 2021

TIME:  08:00am PDT

Abstract

 

The COVID-19 pandemic has placed urgency on precise analysis of rare antigen- and virus-specific T cells. At Miltenyi Biotec, we offer a complete workflow for isolation, stimulation, sorting and analysis of antigen- and virus-specific T cells. Analysis of these rare cells is not only important to reveal whether or not long-term protection is gained after infection or vaccination, but also essential for understanding fundamental immunological processes in immuno-oncology and immune tolerance. Working with antigen-specific T cells can prove challenging to researchers. Critically low cell frequencies, inflammatory environments, unspecific labeling and high background often hamper reliable analysis. Our workflow has been optimized at every step to address key challenges faced by researchers working with these rare cells. The correct combination of products for sample preparation, cell stimulation, pre-enrichment and flow cytometry is key for a successful analysis. We are confident that we can assist you, in even the most challenging research projects and your work on viral threats like COVID-19.

 

Learning Objectives:

  • Find out about our complete workflow for isolation, stimulation, enrichment and analysis of antigen- and virus-specific T cells

  • Overcome key challenges, including low cell frequencies, unspecific labeling and high background staining

  • Optimize your workflow for other rare cells in virus research

 

Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


You May Also Like
Loading Comments...